Ai-Bin Liang (Aibin Liang)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Venues

Oncogene

Cell death & disease

Signal transduction and targeted therapy

Leukemia

This page only lists publications with an associated author ORCID identifier.

Publications

Rong-Yi Shi, Neng Zhou, Li Xuan, Zhong-Hui Jiang, Jing Xia, Jian-Min Zhu, Kai-Ming Chen, Guo-Li Zhou, Guo-Pan Yu, Jun Zhang, Chuanxin Huang, Ai-Bin Liang, Kai-Wei Liang, Hao Zhang, Jian-Feng Chen, Dachuan Zhang, Yi Zhong, Qi-Fa Liu, Guo-Qiang Chen, Cai-Wen Duan
Trafficking circuit of CD8 + T cells between the intestine and bone marrow governs antitumour immunity. Nature cell biology (2024)
Guang-Ming Wang, Wenjun Zhang, Jie Ren, Yu Zeng, Xiuyong Dang, Xiaoxue Tian, Wenlei Yu, Zheng Li, Yuting Ma, Pingping Yang, Jinyuan Lu, Junke Zheng, Bing Lu, Jun Xu, Ai-Bin Liang
The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia. Oncogene 43 (25) (2024)
Huaqing Wang, Jifeng Feng, Yanyan Liu, Zhengzi Qian, Da Gao, Xuehong Ran, Hui Zhou, Lihong Liu, Binghua Wang, Meiyun Fang, Hebing Zhou, Zhenqian Huang, Shi Tao, Zhuowen Chen, Liping Su, Hang Su, Yu Yang, Xiaobao Xie, Huijing Wu, Ping Sun, Guoyu Hu, Ai-Bin Liang, Zhi-Ming Li
Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma. Signal transduction and targeted therapy 9 (1) (2024)
Guang-Ming Wang, Wenjun Zhang, Jie Ren, Yu Zeng, Xiuyong Dang, Xiaoxue Tian, Wenlei Yu, Zheng Li, Yuting Ma, Pingping Yang, Jinyuan Lu, Junke Zheng, Bing Lu, Jun Xu, Ai-Bin Liang
The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia. Oncogene 43 (25) (2024)
Huaqing Wang, Jifeng Feng, Yanyan Liu, Zhengzi Qian, Da Gao, Xuehong Ran, Hui Zhou, Lihong Liu, Binghua Wang, Meiyun Fang, Hebing Zhou, Zhenqian Huang, Shi Tao, Zhuowen Chen, Liping Su, Hang Su, Yu Yang, Xiaobao Xie, Huijing Wu, Ping Sun, Guoyu Hu, Ai-Bin Liang, Zhi-Ming Li
Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma. Signal transduction and targeted therapy 9 (1) (2024)
Li Xie, Chiqi Chen, Tinghua Zhang, Wenqian Yang, Denghao Zheng, Liyuan Cao, Jin Yuan, Yilu Xu, Yaping Zhang, Ligen Liu, Ai-Bin Liang, Zhuo Yu, Junke Zheng
LILRB4 regulates multiple myeloma development through STAT3-PFKFB1 pathway. Cell death & disease 15 (7) (2024)
Li Xie, Chiqi Chen, Tinghua Zhang, Wenqian Yang, Denghao Zheng, Liyuan Cao, Jin Yuan, Yilu Xu, Yaping Zhang, Ligen Liu, Ai-Bin Liang, Zhuo Yu, Junke Zheng
LILRB4 regulates multiple myeloma development through STAT3-PFKFB1 pathway. Cell death & disease 15 (7) (2024)
Huaqing Wang, Jifeng Feng, Yanyan Liu, Zhengzi Qian, Da Gao, Xuehong Ran, Hui Zhou, Lihong Liu, Binghua Wang, Meiyun Fang, Hebing Zhou, Zhenqian Huang, Shi Tao, Zhuowen Chen, Liping Su, Hang Su, Yu Yang, Xiaobao Xie, Huijing Wu, Ping Sun, Guoyu Hu, Ai-Bin Liang, Zhi-Ming Li
Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma. Signal transduction and targeted therapy 9 (1) (2024)
Rong-Yi Shi, Neng Zhou, Li Xuan, Zhong-Hui Jiang, Jing Xia, Jian-Min Zhu, Kai-Ming Chen, Guo-Li Zhou, Guo-Pan Yu, Jun Zhang, Chuanxin Huang, Ai-Bin Liang, Kai-Wei Liang, Hao Zhang, Jian-Feng Chen, Dachuan Zhang, Yi Zhong, Qi-Fa Liu, Guo-Qiang Chen, Cai-Wen Duan
Trafficking circuit of CD8 + T cells between the intestine and bone marrow governs antitumour immunity. Nature cell biology 26 (8) (2024)
Guang-Ming Wang, Wenjun Zhang, Jie Ren, Yu Zeng, Xiuyong Dang, Xiaoxue Tian, Wenlei Yu, Zheng Li, Yuting Ma, Pingping Yang, Jinyuan Lu, Junke Zheng, Bing Lu, Jun Xu, Ai-Bin Liang
The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia. Oncogene 43 (25) (2024)
Guang-Ming Wang, Wenjun Zhang, Jie Ren, Yu Zeng, Xiuyong Dang, Xiaoxue Tian, Wenlei Yu, Zheng Li, Yuting Ma, Pingping Yang, Jinyuan Lu, Junke Zheng, Bing Lu, Jun Xu, Ai-Bin Liang
The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia. Oncogene (2024)
Li Xie, Chiqi Chen, Tinghua Zhang, Wenqian Yang, Denghao Zheng, Liyuan Cao, Jin Yuan, Yilu Xu, Yaping Zhang, Ligen Liu, Ai-Bin Liang, Zhuo Yu, Junke Zheng
LILRB4 regulates multiple myeloma development through STAT3-PFKFB1 pathway. Cell death & disease 15 (7) (2024)
Li Xie, Chiqi Chen, Tinghua Zhang, Wenqian Yang, Denghao Zheng, Liyuan Cao, Jin Yuan, Yilu Xu, Yaping Zhang, Ligen Liu, Ai-Bin Liang, Zhuo Yu, Junke Zheng
LILRB4 regulates multiple myeloma development through STAT3-PFKFB1 pathway. Cell death & disease 15 (7) (2024)
Guang-Ming Wang, Wenjun Zhang, Jie Ren, Yu Zeng, Xiuyong Dang, Xiaoxue Tian, Wenlei Yu, Zheng Li, Yuting Ma, Pingping Yang, Jinyuan Lu, Junke Zheng, Bing Lu, Jun Xu, Ai-Bin Liang
The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia. Oncogene 43 (25) (2024)
Huaqing Wang, Jifeng Feng, Yanyan Liu, Zhengzi Qian, Da Gao, Xuehong Ran, Hui Zhou, Lihong Liu, Binghua Wang, Meiyun Fang, Hebing Zhou, Zhenqian Huang, Shi Tao, Zhuowen Chen, Liping Su, Hang Su, Yu Yang, Xiaobao Xie, Huijing Wu, Ping Sun, Guoyu Hu, Ai-Bin Liang, Zhi-Ming Li
Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma. Signal transduction and targeted therapy 9 (1) (2024)
Xiaoxue Tian, Zeyu Zhu, Guang-Ming Wang, Jun Xu, Ai-Bin Liang, Wenjun Zhang
Inhibition of DEK Enhances Doxorubicin-Induced Apoptosis and Cell Cycle Arrest in T-Cell Acute Lymphoblastic Leukemia Cells. Disease markers 2022 (2022)
Min-Min Lou, Xiao-Qiang Tang, Guang-Ming Wang, Jia He, Fang Luo, Ming-Feng Guan, Fei Wang, Huan Zou, Jun-Ying Wang, Qun Zhang, Ming-Jian Xu, Qi-Li Shi, Li-Bing Shen, Guo-Ming Ma, Yi Wu, Yao-Yang Zhang, Ai-Bin Liang, Ting-Hua Wang, Liu-Lin Xiong, Jian Wang, Jun Xu, Wen-Yuan Wang
Long noncoding RNA BS-DRL1 modulates the DNA damage response and genome stability by interacting with HMGB1 in neurons. Nature communications 12 (1) (2021)
Dongguang Li, Jacob R Bledsoe, Yu Zeng, Wei Liu, Yiguo Hu, Ke Bi, Ai-Bin Liang, Shaoguang Li
A deep learning diagnostic platform for diffuse large B-cell lymphoma with high accuracy across multiple hospitals. Nature communications 11 (1) (2020)
Chunmei Yang, Mixue Xie, Kaifeng Zhang, Hui Liu, Ai-Bin Liang, Ken H H Young, Weidong Han
Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection. Leukemia 34 (11) (2020)
Cheng Zhang, Xiao-Qi Wang, Rong-Li Zhang, Fang Liu, Yi Wang, Zhi-Ling Yan, Yong-Ping Song, Ting Yang, Ping Li, Zhen Wang, Ying-Ying Ma, Lei Gao, Yao Liu, Li Gao, Pei-Yan Kong, Jun Liu, Xu Tan, Jiang F Zhong, Yu-Qing Chen, Ai-Bin Liang, Jin-Hua Ren, Zhen-Yu Li, Jiang Cao, Quan-Li Gao, Jian Zhou, Ying Gao, Ding Zhang, Fang-Yi Fan, Ming-Zhe Han, Robert Peter Gale, Xi Zhang
Donor-derived CD19 CAR-T cell therapy of relapse of CD19-positive B-ALL post allotransplant. Leukemia 35 (6) (2020)

Ai-Bin Liang.css-eqlu8i{font-size:small;padding-left:4px;} (Aibin Liang)

Publication Activity (10 Years)

Top Topics

Top Venues

Ai-Bin Liang (Aibin Liang)